LUTHERVILLE, Md., Aug. 20, 2014 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) today lauded the latest results achieved by the real-time, pseudoephedrine (PSE) blocking system in Kansas. The system, known as the National Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps law enforcement officials track down meth offenders and make arrests. Data released by NPLEx shows electronic technology in Kansas blocked the sale of more than 7,481 boxes of medicine containing PSE during the first seven months of 2014, preventing more than 19,830 grams from potentially being diverted by meth criminals.
Additionally, when compared to the same period in 2013, Kansas sold 6.99% fewer boxes of PSE and reduced the number of individual purchasers by 6.46%.
"NPLEx has proven to be a vital tool for Kansas law enforcement officers working to eradicate meth production in their state," said Charles F. Cichon, executive director of NADDI. "Although it's not a silver bullet, NPLEx does give police the ability to track suspicious purchases of PSE and locate potential meth cooks. When a suspect attempts to purchase ingredients for making meth, NPLEx warns law enforcement officers instantaneously on their smart phones, leading to faster arrests and convictions."
"Now that the system has been in place for several years, we are seeing dramatic results in the targeting and prosecution of meth criminals. With this success, lawmakers can now start to focus on the other aspects of the state's meth problem, including individual drug treatment and addiction."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators